We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,156.00
Bid: 12,124.00
Ask: 12,128.00
Change: -14.00 (-0.12%)
Spread: 4.00 (0.033%)
Open: 12,114.00
High: 12,258.00
Low: 12,114.00
Prev. Close: 12,170.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 3-European stocks post worst week since October on vaccine woes

Fri, 29th Jan 2021 08:20

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)

* STOXX 600 down 3% on the week

* Ericsson jumps on upbeat earnings

* H&M slides as it fears loss in Q1
(Updates to market close)

By Sruthi Shankar

Jan 29 (Reuters) - European stocks slid on Friday, recording
their worst weekly performance since October as concerns around
the slow rollout of COVID-19 vaccines mount, while a retail
trading frenzy led to volatility on Wall Street.

The benchmark STOXX 600 index closed 1.9% lower,
erasing all of January's gains and ending the week down 3.1%

Germany's DAX fell 1.7%, the UK's blue-chip FTSE
100 dropped 1.8% and U.S. stocks fell more than 1% after
underwhelming COVID-19 vaccine data from Johnson & Johnson
.

Concerns around the potential economic damage from a new
strain of the coronavirus in Europe and delays to vaccine
rollouts have dented sentiment in the past few days.

In the U.S., where the stock market enjoyed a stimulus-led
rally last year, volatility was seen following steep gains in
heavily shorted stocks, including Gamestop and AMC
Entertainment after retail traders piled in.

Europe's medicines regulator approved AstraZeneca
and Oxford University's COVID-19 vaccine for people over the age
of 18 on Friday, the third vaccine to be cleared for use in the
European Union.

Europe urgently needs more shots to speed up its inoculation
programme, with AstraZeneca, Pfizer and Moderna
facing difficulties in delivering the shipments to the bloc.

"We're postponing the recovery story a little bit because of
the lockdown measures and challenges for European growth," said
Joseph Little, global chief strategist at HSBC Global Asset
Management, London.

"I'm still optimistic on parts of Europe which have lagged
rather badly, economically and in markets. They could begin to
perform as the cyclical catch-up becomes more important."

Economy-linked stocks of banks, insurers,
miners and oil & gas companies were among the
worst hit this week but Germany and Spain's economies recorded
growth in the fourth quarter, while the French economy
contracted by a smaller than expected rate.

In a busy day for earnings, Sweden's Ericsson
jumped 7.6% after reporting fourth-quarter core earnings ahead
of market estimates on the back of strong sales of 5G equipment.

Daimler edged up 0.9% after it said a strong
fourth quarter helped it post better-than-expected 2020 group
operating profit and that it was optimistic for 2021.

Swedish fashion retailer H&M fell 5.0% as it braced
for a loss in the first quarter after full-year profits
plummeted due to COVID-19.

Europe's earnings season has been largely positive so far.
Of the 8% of STOXX 600 companies that have reported, 78% have
topped profit estimates, according to Refinitiv IBES data.
(Reporting by Sruthi Shankar in Bengaluru; editing by Bernard
Orr and Elaine Hardcastle)

More News
4 Mar 2024 09:31

AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketing authorisation applications for their datopotamab deruxtecan in two types of cancer.

Read more
4 Mar 2024 07:18

AstraZeneca's chemo replacement treatment moves closer to EU approval

(Sharecast News) - European regulators have validated two marketing authorisation applications (MMAs) for AstraZeneca, as the biopharma giant's datopotamab deruxtecan chemotherapy replacement treatment comes one step closer to receiving the green light to treat two types of cancer.

Read more
26 Feb 2024 08:51

AstraZeneca's Voydeya treatment recommended for EU approval

(Alliance News) - AstraZeneca on Monday announced further support from regulators for its first-in-class blood disease treatment.

Read more
26 Feb 2024 07:22

AstraZeneca's blood-disorder drug recommended for EU approval

(Sharecast News) - European regulators has given the green light to AstraZeneca's blood-disorder drug Voydeya, the biopharma giant announced on Monday.

Read more
22 Feb 2024 17:36

EARNINGS AND TRADING: Astra closes Gracell buy, Amicorp "on track"

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and Thursday and not separately reported by Alliance News:

Read more
20 Feb 2024 10:29

AstraZeneca acquires US-based biopharmaceutical company

(Sharecast News) - Drugmaker AstraZeneca revealed late on Monday afternoon that it had successfully completed its acquisition of US-based biopharmaceutical company Icosavax.

Read more
20 Feb 2024 09:40

LONDON BROKER RATINGS: JPMorgan cuts Airtel Africa price target by 28%

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
19 Feb 2024 16:51

LONDON MARKET CLOSE: Europe lacks direction on quiet Monday

(Alliance News) - European markets lacked direction on Monday, after a quiet day as the US markets celebrated George Washington's birthday.

Read more
19 Feb 2024 15:59

London close: Stocks manage gains on globally quiet day

(Sharecast News) - London's financial markets finished in positive territory on Monday, with stocks closing in the green after overcoming minor losses earlier in the session.

Read more
19 Feb 2024 15:39

UPDATE: AstraZeneca completes USD1.1 billion acquisition of Icosavax

(Alliance News) - AstraZeneca PLC on Monday said it has completed the acquisition of Icosavax Inc.

Read more
19 Feb 2024 11:51

LONDON MARKET MIDDAY: Stocks lack direction amid quiet start to week

(Alliance News) - Stock prices in London lacked direction at midday Monday, amid a quiet start to the week.

Read more
19 Feb 2024 08:44

LONDON MARKET OPEN: Stocks drift; Currys surges on takeover interest

(Alliance News) - Stock prices in London were looking for direction early Monday, as investors weighed possible trajectories for US interest rate cuts and a China's economic recovery.

Read more
19 Feb 2024 08:36

TOP NEWS: AstraZeneca celebrates Tagrisso approval and new data

(Alliance News) - AstraZeneca PLC on Monday announced new study data and a new approval for its cancer medication Tagrisso.

Read more
19 Feb 2024 08:03

AstraZeneca's Tagrisso gains FDA approval

(Sharecast News) - Drugmaker AstraZeneca traded higher early on Monday after revealing that a combination of its cancer drug Tagrisso with chemotherapy had gained US approval to treat a particular type of lung cancer.

Read more
19 Feb 2024 07:49

LONDON BRIEFING: MoneySupermarket credits Insurance for growth in 2023

(Alliance News) - Stocks in London are set to fall at Monday's open, as concerns over US inflation trends curb risk appetite, and damp hopes of interest rate cuts from the Federal Reserve.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.